Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

“…Results are presented as mean ± SD. Ceramide: CER, Evogliptin: EVO. *(P < 0.05) significant vs. control group; ^$(P < 0.05) significant vs. …”

The introduction of mutualisms into assembled communities increases their connectance and complexity while decreasing their richness. by Gui Araujo (22170819)

“…<p>Using the invasion model, we investigate the effect of switching on and off (black vs grey) invasions with mutualisms halfway through the simulation (i.e. after 500 assembly events). …”

(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis. by Long Li (6555)

Subjects:

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

The parameters of gas exchange markedly decreased in maize <i>zmstomagen1/2</i> mutant compared with in wild type (WT). by Juan-Juan Xu (18590868)

Lifespan of a single <i>T. utriculata</i> rosette. by Alexandra M. Campbell (3284094)

<i>Tillandsia utriculata</i> death rate data by size class. by Alexandra M. Campbell (3284094)

Variables for the bromeliad agent representing a single <i>T. utriculata</i> rosette. by Alexandra M. Campbell (3284094)

Distribution of population at final time (left) and change in mean MSI at final time (right) from simulations across 1000 parameter sets when weevils are absent (red) and with weev... by Alexandra M. Campbell (3284094)

Histograms of (A) distance measured in meters to nearest neighboring tree given bin widths of 2 m (<i>n</i> = 44), and (B) basal areas of all sampled trees (<i>n</i> = 58; bin widt... by Alexandra M. Campbell (3284094)

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

PRCC values (with <i>p</i>-values in parentheses) for the median final population size and difference in mean MSI at the final time, without weevil predation and with weevil predat... by Alexandra M. Campbell (3284094)

Distribution of final population size (A) and mean change in mean MSI over time (B) over 100 simulations for each parameter set shown in Table 3 in the absence of weevils (left) an... by Alexandra M. Campbell (3284094)

Metabolites with decreasing levels during the development. by Martin Sládek (130663)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

Flow diagram illustrating the sequence of procedures executed during one time step defined as tick, each of which represents one week. by Alexandra M. Campbell (3284094)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)